Resources

Results 901 - 925 of 1093

Building and strengthening health systems are difficult and take time.

Inside this issue: SPS Afghanistan Associate Award Stakeholders Update Pharmacy Curriculum National Food & Medicine Board Hosts Workshop Welcome from the Chief of Party   SPS & GDPA Attend International Conference SPS Assists MoPH with Emergency Medicine Order   Heath Communications Message Widely Broadcasted Transition of Drug Management Unit Completed

The Ministry of Public Health (MoPH), with technical and financial assistance of the Strengthening Pharmaceutical Systems (SPS) project funded by the US Agency for International Development (USAID), carried out the medicines safety assessment from March to August 2013 in six Kabul hospitals.

In Afghanistan, 20 non-governmental organizations are contracted by the Ministry of Public Health (MOPH) to provide support to the Basic Package for Health Services and Essential Package for Hospital Services (BPHS/EPHS) in all 34 provinces. The Pharmaceutical Logistics Information System (PLIS) was tested in all these NGOs in all the provinces in September 2013.

This national standard treatment guidelines (STGs) manual is designed for use at the first-level (i.e., primary) facilities delivering the Basic Package of Health Services (BPHS).

The General Directorate of Pharmaceutical Affairs (GDPA) operates within the Ministry of Public Health (MOPH) in Afghanistan and is the prime body for managing pharmaceutical activities within the country in both the public and private sectors. MOPH recognizes the current difficulties on essential medicines and wishes to see a harmonized and integrated approach with a nationally coordinated m

The pharmaceutical regulatory situation in Afghanistan is generally considered to be weak with most of the activities in the private sector and, to a l arge extent, in the public sector largely uncontrolled.

This framework seeks to outline a national strategy for the development of pharmaceutical HR in the public and private sectors in Afghanistan to produce a stronger pharmaceutical system that responds to the population’s needs.

The pharmaceutical services competency framework defines competencies for core tasks in each area. Expert practitioners in each of the service areas identified the main tasks.

For largely historical reasons of development in a post- or ongoing conflict situation, the current essential medicines supply mechanisms in Afghanistan are characterized by multiple funding sources and a large number of active players, giving rise to fragmented and, currently, largely uncoordinated service from multiple, vertical supply streams of varying efficiency. This is not to say that

The Afghanistan Ministry of Public Health (MoPH), with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program, carried out a survey of medicines quality in Afghanistan. The survey was conducted for the MoPH to determine whether medicines in the public and private sectors of Afghanistan comply with established international pharmacopeial standards.

The Afghanistan Ministry of Public Health (MoPH) with technical assistance from the Strengthening Pharmaceutical Systems (SPS) Program carried out a qualitative survey of medicines quality assurance assessment in Afghanistan.

The MoPH established the National Medicines and Food Board (NMFB) in 2009, as a multidisciplinary body to oversee and catalyze regulatory activities in medicines and food products.

This medicine use study was planned, conducted, and analyzed by the Strengthening Pharmaceutical Systems (SPS) Program of Management Sciences for Health (MSH) in collaboration with the Ministry of Public Health (MoPH). Data collection for the study was conducted in March and April, 2009.

SPS conducted an initial assessment of the existing regulatory mechanisms and systems for food and medicinal products with the goal of proposing options and approaches for a well-developed regulatory framework. The assessment team interviewed 24 stakeholders related to food and medicine regulation (7 food-specific, 6 medicines-specific, and 11 related to both). 

An uninterrupted supply of pharmaceutical products is required to ensure the provision of clinical services according to the Basic Package of Health Services (BPHS) and the Essential Package of Hospital Services (EPHS).

During the course of its work in Afghanistan, the SPS program has identified multiple challenges confronting the pharmaceutical system in Afghanistan that combine to limit the access to quality pharmaceuticals by the Afghan population.

One of the biggest challenges developing countries face in their fight against counterfeit and substandard medicines is building their technical capacity to regulate medicines. Without effective and affordable analytical technologies, the quality of the medicines cannot be secured in the country.

The objective of the curriculum mapping activity was to map the current pharmacy assistant curricula in the GIHS and one private Pharmacy school against the Competency Framework for Pharmaceutical Services to identify strengths and gaps in the current curriculum, and make recommendations for improvement.

The Nangarhar Public Health Directorate, the HealthNet Trans Psychosocial Organization (HN TPO), and the USAID-funded Strengthening Pharmaceutical Systems (SPS) Program implemented by Management Sciences for Health (MSH) are pleased to present the 2013 edition of the Surgical Antibiotic Prophylaxis Standard Treatment Guidelines.

It is a delightful opportunity for the Stomatology hospital DTC Committee and the management team to be able to be engaged in the development of stomatology standard therapeutic Guidelines.

The development of a set of standard treatment guidelines from senior eyes specialists intended for use by individual health practitioners, particularly to newly Graduated physicians joining as trainees to the Noor Hospital and to those working in outpatients clinics, and is a priority for the health authorities.

This standard operating procedure (SOP) describes the procedures to be used by the members of Pharmacovigilance Department of National Medicines and Healthcare Products Regulatory Authority (NMHRA), Medicine Safety Committee (MSC) and by health care professionals for the recording, management and reporting of suspected adverse drug reactions (ADRs) and other suspected adverse events (AEs) that are

These guidelines are intended to ensure that medicines marketed in Afghanistan are safe, efficacious, and of good quality; assist applicants with the preparation of applications for the registration of multisource (generic) products by providing clear general guidance on the format of the dossiers; provide guidance on technical and other general data requirements.

Prior to the efforts of the MoPH supported by the USAID Strengthening Pharmaceutical Systems Project (SPS) in September 2010, no comprehensive information existed regarding the density and distribution of pharmaceutical personnel providing pharmaceutical services, their competencies, and human resources issues.

Pages

Printer Friendly Version